|
| 36828718 | The time is now for committed and comprehensive action to attain more broadly protective coronavirus vaccines: The coronavirus vaccines R&D roadmap. | Vaccine | 2023 |
| 37596199 | Dr. Edward Jenner's House and the 200th anniversary of his death. | Vaccine | 2023 |
| 38076130 | Associations of adaptive immune cell subsets with measles, mumps, and Rubella-Specific immune response outcomes. | Heliyon | 2023 |
| 37798208 | Latest developments in vaccine research: Selected papers from the 16th annual vaccine congress. | Vaccine | 2023 |
| 37553265 | Trust and science: Public health's home field advantage in addressing vaccine hesitancy and improving immunization rates. | Vaccine | 2023 |
| 37778899 | Genome-wide determinants of cellular immune responses to mumps vaccine. | Vaccine | 2023 |
| 37600811 | Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation. | Front Immunol | 2023 |
| 37147202 | Corrigendum to "A review of 2023 adult immunization schedule updates" [Vaccine 41(16) (2023) 2631-2633]. | Vaccine | 2023 |
| 37205333 | Genome-Wide Determinants of Cellular Immune Responses to Mumps Vaccine. | medRxiv | 2023 |
| 37336615 | The use of AI-generated text and scientific publishing: Issues and a way forward. | Vaccine | 2023 |
| 36966076 | A review of 2023 adult immunization schedule updates. | Vaccine | 2023 |
| 36803903 | Vaccinomics: A scoping review. | Vaccine | 2023 |
| 34863620 | Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines. | Vaccine | 2022 |
| 35680552 | Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services. | Clin Infect Dis | 2022 |
| 35439529 | Detection of SARS-CoV-2 peptide-specific antibodies in Syrian hamster serum by ELISA. | J Immunol Methods | 2022 |
| 35768434 | Comparability of clinical trials and spontaneous reporting data regarding COVID-19 vaccine safety. | Sci Rep | 2022 |
| 35577634 | John D. Bailey retiring after more than 20⿯years of service to Vaccine. | Vaccine | 2022 |
| 35574172 | Immunization of healthcare personnel: A continuing issue. | Vaccine X | 2022 |
| 35534313 | Readability of COVID-19 vaccine information for the general public. | Vaccine | 2022 |
| 35817645 | Shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccination. | Vaccine | 2022 |
| 35782478 | Distorted Human Decision-Making as a Critical Aspect of Pandemic Planning and Preparedness. | Yale J Biol Med | 2022 |
| 36464465 | Year 3 of COVID-19: Harsh Truths, Brutal Realities, and Glimmers of Hope. | Mayo Clin Proc | 2022 |
| 36560767 | T Cell Transcriptional Signatures of Influenza A/H3N2 Antibody Response to High Dose Influenza and Adjuvanted Influenza Vaccine in Older Adults. | Viruses | 2022 |
| 36109277 | A research and development (R&D) roadmap for broadly protective coronavirus vaccines: Setting a path to address coronavirus threats. | Vaccine | 2022 |
| 36366367 | Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population. | Vaccines (Basel) | 2022 |
| 36100624 | Evaluating immunogenicity of pathogen-derived T-cell epitopes to design a peptide-based smallpox vaccine. | Sci Rep | 2022 |
| 35994504 | The Influence of Sex, Body Mass Index, and Age on Cellular and Humoral Immune Responses Against Measles After a Third Dose of Measles-Mumps-Rubella Vaccine. | J Infect Dis | 2022 |
| 36163091 | The human immune response to vaccines is symphonic, polyphonic, homophonic, and megaphonic. | Vaccine | 2022 |
| 36116460 | Prevention of monkeypox with vaccines: a rapid review. | Lancet Infect Dis | 2022 |
| 34952760 | Proteomic assessment of humoral immune responses in smallpox vaccine recipients. | Vaccine | 2022 |
| 34968746 | Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents. | Clin Immunol | 2022 |
| 35174502 | Comparative assessment of allergic reactions to COVID-19 vaccines in Europe and the United States. | Allergy | 2022 |
| 35197577 | Vaccine safety in an era of novel vaccines: a proposed research agenda. | Nat Rev Immunol | 2022 |
| 35341648 | Decreasing routine vaccination rates in children in the COVID-19 era. | Vaccine | 2022 |
| 35137144 | Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccination. | J Infect Dis | 2022 |
| 32703743 | A global agenda for older adult immunization in the COVID-19 era: A roadmap for action. | Vaccine | 2021 |
| 33543775 | Migraine treatment and COVID-19 vaccines: No cause for concern. | Headache | 2021 |
| 33824043 | The development of COVID-19 vaccines in the United States: Why and how so fast? | Vaccine | 2021 |
| 33676614 | Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster. | Lancet | 2021 |
| 33485647 | The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice? | Vaccine | 2021 |
| 33846043 | Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study. | Vaccine | 2021 |
| 33846042 | The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety. | Vaccine | 2021 |
| 33818775 | Transcriptional signatures associated with rubella virus-specific humoral immunity after a third dose of MMR vaccine in women of childbearing age. | Eur J Immunol | 2021 |
| 33536137 | Vaccines, masks, distancing and credibility: An urgent warning for pandemic management. | Vaccine | 2021 |
| 33730754 | Antibody Dynamics, Seroreversion, and Persistence After Severe Acute Respiratory Syndrome Coronavirus 2: Another Answer. | Clin Infect Dis | 2021 |
| 33533072 | Prediction of post-vaccination Guillain-Barré syndrome using data from a passive surveillance system. | Pharmacoepidemiol Drug Saf | 2021 |
| 33612343 | Improving COVID-19 vaccine acceptance: Including insights from human decision-making under conditions of uncertainty and human-centered design. | Vaccine | 2021 |
| 34404556 | Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination. | Vaccine | 2021 |
| 34483021 | Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies. | Vaccine | 2021 |
| 34416408 | Update on Influenza Vaccines: Needs and Progress. | J Allergy Clin Immunol Pract | 2021 |